Acute Myeloid Leukemia Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...
Nature2y
Reviewer Recognition
Dr. Haferlach is the co-founder and general manager of the MLL Munich Leukemia Laboratory and the MLL MVZ practice. The laboratory processes over 133,000 blood or bone marrow samples annually ...